Search results for "MEDLINE"

showing 10 items of 2097 documents

Medical management of Crohn's disease

2011

The medical approach to Crohn's disease has been modified in recent years thanks to the introduction of new therapies, like biologics. Also, well-designed studies and systematic reviews have allowed better evaluation of the role of old drugs like steroids and immunosuppressors. This review aims to evaluate the recent evidence on the medical approach to Crohn's disease in the different settings of the disease.Randomized controlled trials and meta-analyses were included in the review. The research on all the studies discussed was based on the Cochrane Library, Medline and Embase, using the following medical subject headings: Crohn's disease, clinical trial, therapy, 5-aminosalicylic acid, ste…

Budesonidemedicine.medical_specialtyPathologyAnti-Inflammatory AgentsMEDLINEDiseaseCochrane LibraryManagement of Crohn's diseaselaw.inventionCrohn DiseaseRandomized controlled trialAdrenal Cortex HormoneslawmedicineHumansPharmacology (medical)BudesonideIntensive care medicineBone Marrow TransplantationPharmacologyBiological ProductsTumor Necrosis Factor-alphabusiness.industryRemission InductionGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsIntestinesClinical trialAminosalicylic AcidsMethotrexateTreatment OutcomeSystematic reviewPurinesbusinessImmunosuppressive Agentsmedicine.drugExpert Opinion on Pharmacotherapy
researchProduct

Sure he's dead? Be wise.

2013

BurialConversion DisorderPhobic DisordersPhilosophyMEDLINEmedicineHumansFemaleGeneral MedicineMedical emergencymedicine.diseaseLawPathology and Forensic MedicineJournal of forensic and legal medicine
researchProduct

EPI-CT: design, challenges and epidemiological methods of an international study on cancer risk after paediatric and young adult CT

2015

Computed tomography (CT) has great clinical utility and its usage has increased dramatically over the years. Concerns have been raised, however, about health impacts of ionising radiation exposure from CTs, particularly in children, who have a higher risk for some radiation induced diseases. Direct estimation of the health impact of these exposures is needed, but the conduct of epidemiological studies of paediatric CT populations poses a number of challenges which, if not addressed, could invalidate the results. The aim of the present paper is to review the main challenges of a study on the health impact of paediatric CTs and how the protocol of the European collaborative study EPI-CT, coor…

CT scanmedicine.medical_specialtyPediatricsNeoplasms Radiation-InducedBRAIN-TUMORSPopulationMEDLINEEpidemiological methodPediatricsRisk AssessmentRADIATION-EXPOSURERadiation ProtectionATOMIC-BOMB SURVIVORSMONTE-CARLORisk FactorsNORTHERN ENGLANDEpidemiologyMedicine and Health Sciencescohort studymedicineHumanscancerCOMPUTED-TOMOGRAPHYeducationWaste Management and DisposalTHYROID-CANCEReducation.field_of_studybusiness.industryepidemiological methodsPublic Health Environmental and Occupational HealthGeneral MedicineEuropeRadiological weaponleukaemiaEmergency medicineCohortSUBSEQUENT RISKCHILDHOOD LEUKEMIAIONIZING-RADIATIONEpidemiologic MethodsTomography X-Ray ComputedRisk assessmentbusinessCohort studyJournal of Radiological Protection
researchProduct

Erratum to “Time trends and short term projections of cancer prevalence in France” [Cancer Epidemiol. 56 (2018) 97–105]

2018

IF 2.888 (2017); International audience

Cancer ResearchEpidemiologyTime trendsbusiness.industryPublished ErratumMEDLINECancerTime trends[SDV.CAN]Life Sciences [q-bio]/Cancermedicine.diseaseShort-term projectionsTerm (time)Projection scenariosOncologyPrevalenceMedicineFlexible modelsbusinessCancer prevalenceDemographyCancer Epidemiology
researchProduct

Recurrences following treatment of proliferative verrucous leukoplakia: A systematic review and meta-analysis.

2021

Objective A systematic review and meta-analysis was made of the incidence of recurrences in patients with proliferative verrucous leukoplakia subjected to different types of treatment. Methods The study was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines. A literature search was made in the Medline (PubMed), EMBASE and Web of Science databases, together with a manual search, covering the period from 1985 to January 2020, with no language restrictions. Studies were included if they described treatments applied to at least 10 patients with the corresponding outcomes. Methodological quality was evaluated using Jadad sca…

Cancer ResearchFunnel plotmedicine.medical_specialtyMEDLINEPathology and Forensic Medicine03 medical and health sciences0302 clinical medicinemedicineHumansbusiness.industryIncidence (epidemiology)Incidence030206 dentistryPublication biasMiddle AgedRandom effects modelDermatologyJadad scaleSystematic reviewOtorhinolaryngology030220 oncology & carcinogenesisMeta-analysisPeriodonticsFemaleOral SurgeryLeukoplakia OralNeoplasm Recurrence LocalbusinessJournal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral PathologyREFERENCES
researchProduct

Epigenomics in acute cerebrovascular diseases.

2020

Cancer ResearchMEDLINEBiologyDNA MethylationBioinformaticsBrain IschemiaEpigenesis GeneticCerebrovascular DisordersMicroRNAsDNA methylationGeneticsHumansEpigenesisEpigenomicsIschemic StrokeEpigenomics
researchProduct

Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Informat…

2006

International audience; In collaboration with 62 population-based cancer registries contributing to the Automated Childhood Cancer Information System (ACCIS), we built a database to study incidence and survival of children and adolescents with cancer in Europe. We describe the methods and evaluate the quality and internal comparability of the database, by geographical region, period of registration, type of registry and other characteristics. Data on 88,465 childhood and 15,369 adolescent tumours registered during 1978-1997 were available. Geographical differences in incidence are caused partly by differences in definition of eligible cases. The observed increase in incidence rates cannot b…

Cancer ResearchPediatricsDatabases FactualMESH: RegistriesMESH : Child Preschool[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineMESH : ChildNeoplasmsMESH: ChildEpidemiologyMedicineMESH: NeoplasmsRegistries030212 general & internal medicineMESH: IncidenceChildeducation.field_of_studyIncidenceIncidence (epidemiology)ComparabilityMESH: Infant NewbornQuality - methods - childhood cancer - EuropeMESH : InfantMESH : AdultMESH: InfantMESH : Incidence3. Good healthEuropeMESH: Reproducibility of ResultsOncologyChild Preschool030220 oncology & carcinogenesisMESH: Survival AnalysisAdultmedicine.medical_specialtyAdolescentPopulationMESH : EuropeMEDLINE[SDV.CAN]Life Sciences [q-bio]/CancerMESH : Databases FactualMESH : Infant Newborn03 medical and health sciencesEnvironmental healthMESH : AdolescentHumanseducationSurvival analysisMESH: AdolescentMESH: Humansbusiness.industryMESH : Reproducibility of ResultsMESH: Child PreschoolMESH : HumansInfant NewbornInfantReproducibility of ResultsCancerMESH: Adultmedicine.diseaseSurvival AnalysisMESH: Databases FactualMESH : NeoplasmsData qualityMESH: EuropeMESH : Survival AnalysisbusinessMESH : Registries
researchProduct

Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment†

2020

### Highlights There is no clear definition of orphan symptoms. There is a group of symptoms that are seldom evaluated in most symptom assessment tools which can be considered as orphan symptoms.1 These are generally prevalent symptoms that are unaddressed in clinical practice, yet often not reported by the patients or by healthcare professionals.2 Orphan symptoms may be defined as symptoms not regularly assessed in clinical practice, and consequently little studied and not properly treated. No epidemiological or clinical studies generally exist to gauge the prevalence of the symptoms chosen; nevertheless, these symptoms are distressing for patients and their families. Orphan symptoms remai…

Cancer ResearchPediatricsmedicine.medical_specialtydiagnosisoncological therapiesMEDLINElcsh:RC254-282Quality of lifeEpidemiologymedicine1506Restless legs syndromeOriginal Researchtreatmentbusiness.industryEvidence-based medicineorphan symptomsmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensRectal tenesmusclinical practice guidelines; diagnosis; oncological therapies; orphan symptoms; treatmentOncologymedicine.symptombusinessMyoclonusclinical practice guidelinesMuscle crampESMO Open
researchProduct

In the literature: June 2021

2021

Cancer ResearchText miningOncologybusiness.industryMEDLINELibrary scienceMedicineNewsbusinessESMO Open
researchProduct

Unknown primary tumors

2011

An unknown primary tumor (UPT) is defined by the presence of a metastatic cancer without a known primary site of origin despite a standardized diagnostic workup. Clinically, UPTs show rapid progression and early dissemination, with signs and symptoms related to the metastatic site. The molecular bases of their biology remain largely unknown, with no evidence as to whether they represent a distinct biological entity. Immunohistochemistry remain the best diagnostic tool in term of cost-effectiveness, but the time-consuming "algorithmic process" it relies on has led to the application of new molecular techniques for the identification of the primary site of UPTs. For example, several microarra…

Cancer Researchbusiness.industryGene Expression ProfilingBiological entityMEDLINETreatment optionsSigns and symptomsBioinformaticsFunctional imagingMicroRNAsOncologyUnknown primary tumors UPTImmunologyUnknown Primary TumorsGeneticsUnknown primaryAnimalsHumansNeoplasms Unknown PrimaryMedicinebusinessSite of originBiochimica et Biophysica Acta (BBA) - Reviews on Cancer
researchProduct